Preclinical pharmacokinetics and stability of isophosphoramide mustard-Reference-Cited by-同舟云学术

Preclinical pharmacokinetics and stability of isophosphoramide mustard

Published:1994 Issue:5 Volume:33 Page:391-398
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother. Pharmacol.

Author:

Zheng Jenny Jingwen,Chan Kenneth K.,Muggia Franco

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/BF00686268.pdf

Reference62 articles.

1. Phelan ET, Vietti TJ, Valeriote FA, Coulter D (1981) Comparison of cytotoxic action of iphosphamide and cyclophosphamide. Anticancer Res 1: 149?154

2. Lewis LD, Meanwell CA (1990) Ifosfamide pharmacokinetics and neurotoxicity (letter). Lancet 335: 175?176

3. Sarosy, G (1989) Ifosfamide-pharmacologic overview. Semin Oncol 161: 2?8

4. Allen LM, Creaven PJ (1972) In vitro activation of isophosphamide (NSC-109724) a new oxazaphosphorine, by rat liver microsomes. Cancer Chemother Rep 56: 603?610

5. Norpoth K (1969) Untersuchungen zur oxydativen Umsetzung von Endoxan in vivo und in vitro. Thesis (Habilitationsschrift) Westphalian Wilhelm University, Münster

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Intratumor Pharmacokinetic/Pharmacodynamic Model for the Hypoxia-Activated Prodrug Evofosfamide (TH-302): Monotherapy Activity is Not Dependent on a Bystander Effect;Neoplasia;2019-02

2. Preactivated Oxazaphosphorines Designed for Isophosphoramide Mustard Delivery as Bulk Form or Nanoassemblies: Synthesis and Proof of Concept;Journal of Medicinal Chemistry;2014-12-23

3. Protein Binding;Cancer Drug Discovery and Development;2013-11-30

4. Extravascular use of drug-eluting beads: A promising approach in compartment-based tumor therapy;World Journal of Gastroenterology;2013

5. Investigation of ifosfamide nephrotoxicity induced in a liver-kidney co-culture biochip;Biotechnology and Bioengineering;2012-08-28